We proudly present our videos filmed at the Interdisciplinary Conference on Psychedelic Research (ICPR) in June 2024, featuring many fascinating new research findings and incredible insights from world-renowned scientists and authors.
It is always one of the highlights of the year to attend the International Conference on Psychedelic Research (ICPR) and submerge into the mysterious world of psychedelics. This is a rapidly growing multidisciplinary research field with many exciting dimensions from the treatment of mental health problems to spiritual growth, from philosophy of mind to psychedelic art and culture. Psychedelics hold a promise to revolutionise our thinking on not one of these subjects. We interviewed many conference speakers and produced a longer (31:57) and shorter (5:39) video, we hope you will find these films helpful in gaining better understanding on how these substances catalyse social, psychological, cultural and spiritual change.
The shorter (5:39) film:
The longer (31:57) film:
Chapters:
00:00 Intro
01:17 What are psychedelics? Gül Dölen, MD, PhD.
02:25 What are the neurobiological mechanisms of psychedelics? Gül Dölen, MD, PhD.
03:16 The importance of psychedelic research in treating mental health problems. Pia Dijkstra, Minister of Healthcare, Government of The Netherlands.
04:08 How psychedlics help change the lives of clinical trial patients. Leonie Schneider, BSc & Ian Roullier, MA.
06:03 So psychedelics are the master keys, but what do they do in the brain? Gül Dölen, MD, PhD.
07:43 How could psychedelics treat obsessive compulsive disorder (OCD)? Jamila Hokanson, MD.
09:10 The potential of psychedelics to treat addiction. Wim van den Brink, MD, PhD.
10:06 What are the new research frontiers for MAPS? Rick Doblin, PhD.
11:17 How is psychedelic assisted psychotherapy different from traditional talking therapy? Janis Phelps, PhD.
12:44 How can we deal with the difficult, challenging psychedelic experiences? Rosalind Watts, PhD.
13:59 Why was there a need to create an organization for psychedelic trial patients? Leonie Schneider, BSc & Ian Roullier, MA.
14:33 There are many patients who are desperately waiting for legal access to psychedelic treatments. But there are also people who say that we move too fast, and we need to ensure ethical standards and the evidence base. How can we find a balance between the two? Leonie Schneider, BSc & Ian Roullier, MA.
15:51 Can psychedelic treatment find its way into mainstream care? Marc B. Aixalá and Nicolas Langlitz, MD, PHD., Elliot Marseille, DRPH, MPP.
19:21 The psychedelic renaissance vs. the counterculture. Eric Davies, PhD., Nicolas Langlitz, MD, PHD., Thomas Metzinger, PHD,
22:49 Psychedelics and the broader drug policy reform. Rick Doblin, PhD., Ethan Nadelmann, JD, PHD,
24:57 what would be the optimal regulation for non-medical use of psychedelics? Ethan Nadelmann, JD, PHD,
26:09 How could psychedelics move in betteer ways to the mainstream culture? Robert Jesse.
27:05 Psychedelic science and spirituality, mystical types of experiences. Robert Jesse.
28:26 Psychedelics and philosophy, the meaning of consciousness. Thomas Metzinger, PHD.
Reporter: Péter Sárosi
Filming and editing: István Gábor Takács
